xylazine has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Docherty, JR; McDaid, J | 1 |
| Docherty, JR; Lavelle, A; Leong, S; Rajamani, K | 1 |
2 other study(ies) available for xylazine and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Anesthesia; Animals; Blood Pressure; Electric Stimulation; Electrodes; Male; Methiothepin; N-Methyl-3,4-methylenedioxyamphetamine; Pentobarbital; Phenylephrine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Serotonin Antagonists; Tachycardia; Xylazine | 2001 |
Prejunctional actions of methylenedioxymethamphetamine in vas deferens from wild-type and alpha(2A/D)-adrenoceptor knockout mice.
Topics: Adrenergic Agents; Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Animals; Desipramine; Dose-Response Relationship, Drug; Electric Stimulation; Female; Genotype; Heart Atria; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Contraction; N-Methyl-3,4-methylenedioxyamphetamine; Neuromuscular Junction; Nifedipine; Norepinephrine; Oxymetazoline; Receptors, Adrenergic, alpha-2; Tritium; Vas Deferens; Vasodilator Agents; Xylazine | 2001 |